Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Danaher (DHR)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HCA Healthcare (HCA – Research Report) and Danaher (DHR – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
HCA Healthcare (HCA)
Jefferies analyst Brian Tanquilut maintained a Buy rating on HCA Healthcare yesterday and set a price target of $590.00. The company’s shares closed last Wednesday at $491.23.
According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of
HCA Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $527.13, a 5.5% upside from current levels. In a report issued on January 27, TipRanks – Google also upgraded the stock to Buy with a $541.00 price target.
See today’s best-performing stocks on TipRanks >>
Danaher (DHR)
In a report released yesterday, Daniel Brennan from TD Cowen maintained a Buy rating on Danaher, with a price target of $270.00. The company’s shares closed last Wednesday at $224.54.
According to TipRanks.com, Brennan is a 5-star analyst with an average return of
Danaher has an analyst consensus of Strong Buy, with a price target consensus of $267.00, which is a 16.6% upside from current levels. In a report released yesterday, TipRanks – DeepSeek also upgraded the stock to Buy with a $263.00 price target.
